auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Recipient
Spartan Bioscience IncDepartment
National Research Council CanadaAmount
$75.0K
Program
CanExport SMEsProvince
ONType
Contribution
Agreement Number
172-2020-2021-Q2-953830
Purpose
To commercialize Spartan’s medical platform. We are commercializing the CYP2C19 test upon the success of the European landmark POPular Genetics clinical trial and the COVID19 test to fight the global pandemic.
Spartan Bioscience Inc × National Research Council Canada
3 grants totalling $224.3K
CanExport SMEs
1,000 grants totalling $35.6M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| NP Aerospace (Canada) Limited | $75.0K | CanExport SMEs |
| BioNeutra North America Inc. | $75.0K | CanExport SMEs |
| HERBALAND NATURALS INC. | $75.0K | CanExport SMEs |
| Aspect Biosystems Ltd. | $74.9K | CanExport SMEs |
| Spartan Bioscience Inc | $74.6K | CanExport SMEs |